Home Restore Medical

Restore Medical

In operation
Series B
Developer of Heart Failure Therapies
Basic
Enterprise Profile

Basic Information

Restore Medical is committed to improving the treatment of congestive heart failure (CHF) by developing innovative and disruptive medical devices to reduce hospitalizations, mortality, and morbidity. Restore Medical has developed the first and only transcatheter pulmonary artery banding (PAB) system for the treatment of HFrEF patients.
Restore Medical Ltd.
Israel
less than 15 people
January 01, 2015
info@restoremedical.co

Enterprise Profile

Industrial Sector
Medical Device R&D and Design Therapeutic Manufacturing
Concept
Therapeutic Products Heart Failure and Cardiomyopathy
Application Scenarios
High-Value Medical Consumables Medical Device Consumables